Back

Evaluating the risk of rhabdomyolysis and myopathy associated with concomitant use of dronedarone and statins using real-world data

17 March 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Atrial Fibrillation - Treatment Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Chuntao Wu

Sanofi, Bridgewater (United States of America)

47 More presentations in this session

Presentation thumbnail
Doctor M. Tanaka (Kobe, JP)
Abstract
Presentation thumbnail
Doctor A. Kobori (Kobe, JP)
Abstract
Presentation thumbnail
Doctor Y. Sasaki (Kobe, JP)
Abstract
Presentation thumbnail
Doctor J. Morita (Sapporo, JP)
Abstract
Presentation thumbnail
Doctor G. Mugnai (Verona, IT)

Access the full session

Session thumbnail
Poster session 1 - Atrial Fibrillation - Treatment

The Event

Event poster

EHRA 2019

17 March 2019 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources